Abilia acquires Cognita AS
Cognita has since many years established a strong position in assistive products in Norway. The company’s turnover in 2021 was 15 mNOK with good profitability. Abilia pays 12 mNOK in cash on closing, which is planned for June 1, 2022. The acquisition is expected to have a marginally positive impact on MedCap’s earnings per share.
”The acquisition of Cognita broadens Abilia’s portfolio in Norway and is in line with the strategy to build on Abilia’s strong position within assistive products and welfare technology”, says Anders Dahlberg, CEO MedCap AB.
For more information, contact:
Anders Dahlberg, CEO, Mobile 46 704 269 262, e-mail email@example.com
MedCap builds successful life sciences companies to improve people's lives. MedCap unites the strengths of a larger the company with the smaller companies' entrepreneurial power, agility, and business acumen. MedCap is publicly listed on NASDAQ Stockholm OMX, with the symbol MCAP. More information is available on the company web site www.medcap.se.